dipyridamole has been researched along with Thrombophilia in 3 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Thrombophilia: A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malacaria, B | 1 |
| Feloney, CD | 1 |
| Maruyama, I | 1 |
| Landolfi, R | 1 |
| Di Gennaro, L | 1 |
1 review available for dipyridamole and Thrombophilia
| Article | Year |
|---|---|
[Molecular mechanisms of the therapeutic agents for kidney diseases: Anti-platelets/anti-coagulant medicines].
Topics: Anticoagulants; Dipyridamole; Fibrin; Humans; Kidney Diseases; Platelet Activation; Platelet Aggrega | 2006 |
2 other studies available for dipyridamole and Thrombophilia
| Article | Year |
|---|---|
Going with the flow of anticoagulant therapy.
Topics: Anticoagulants; Aspirin; Dipyridamole; Heparin; Humans; Patient Education as Topic; Platelet Aggrega | 2003 |
Prevention of thrombosis in polycythemia vera and essential thrombocythemia.
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; | 2008 |